# FDA Inspection 1046031 - Agios Pharmaceuticals, INC. - March 09, 2018

Source: https://www.keypedia.com/records/fda_inspections/agios-pharmaceuticals-inc/7c56f9dd-3dc7-4309-9737-94c5f1627cf7
Source feed: FDA_Inspections

> FDA Inspection 1046031 for Agios Pharmaceuticals, INC. on March 09, 2018. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1046031
- Company Name: Agios Pharmaceuticals, INC.
- Inspection Date: 2018-03-09
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1152494 - 2021-09-16](https://www.keypedia.com/records/fda_inspections/agios-pharmaceuticals-inc/ad2f9025-64b1-41a4-94b1-d93e9e449a20)

Company: https://www.keypedia.com/companies/agios-pharmaceuticals-inc/56e211c0-dde4-4267-a2fa-29bed2c57c05

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c